Cargando…
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Plasminogen activator inhibitor 1 (PAI-1) also known as serpin E1 or endothelial plasminogen activator inhibitor, is produced from endothelial cells and adipose tissue. PAI-1 inhibits tissue plasminogen activator (tPA) and urokinase (uPA) preventing activation of plasminogen and fibrinolysis. Gestat...
Autores principales: | Batiha, Gaber El-Saber, Al-kuraishy, Hayder M., Al-Maiahy, Thabat J., Al-Buhadily, Ali K., Saad, Hebatallah M., Al-Gareeb, Ali I., Simal-Gandara, Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454110/ https://www.ncbi.nlm.nih.gov/pubmed/36076264 http://dx.doi.org/10.1186/s13098-022-00900-2 |
Ejemplares similares
-
New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2023) -
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The Looming Effects of Estrogen in Covid-19: A Rocky Rollout
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Concept and connotation of oxidative stress in preeclampsia
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2018) -
Role of dyslipidemia in the development of early-onset preeclampsia
por: Al-Maiahy, Thabat J., et al.
Publicado: (2021)